Onconetix Inc
NASDAQ:ONCO
Onconetix Inc
NASDAQ:ONCO
Price:
3.22
USD
6.27%
Market Cap:
$11.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Onconetix Inc
NASDAQ:ONCO
|
US |
|
I
|
Inspire Veterinary Partners Inc
NASDAQ:IVP
|
US |
|
Distil PLC
LSE:DIS
|
UK |
|
T
|
Tele Columbus AG
XHAM:TC1
|
DE |
|
Hansol Chemical Co Ltd
KRX:014680
|
KR |
|
Sapporo Holdings Ltd
TSE:2501
|
JP |
|
E
|
Envictus International Holdings Ltd
SGX:BQD
|
SG |
|
Chugoku Electric Power Co Inc
TSE:9504
|
JP |
|
Formosa Chemicals & Fibre Corp
TWSE:1326
|
TW |
|
T
|
Tarkett SA
PAR:TKTT
|
FR |
|
Digital Holdings Inc
TSE:2389
|
JP |
Multiples-Based Value
The Multiples-Based Value of one
ONCO
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 3.22 USD,
Onconetix Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ONCO Multiples-Based Value
LOCKED
Multiples Across Competitors
ONCO Competitors Multiples
Onconetix Inc Competitors
Onconetix Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Onconetix Inc
NASDAQ:ONCO
|
11.5m USD | 4.1 | -0.1 | -1.6 | -1.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
373.2B USD | 6.1 | 88.9 | 14.7 | 20.5 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD | 6.2 | -96.2 | 951.3 | -107.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.9B USD | 5.7 | 19.9 | 12.4 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.2B USD | 9.4 | 28.4 | 21.3 | 22.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80B USD | 5.5 | 17.5 | 12.9 | 14.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69.6B AUD | 3.2 | 34.9 | 11.5 | 14.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
